Originator Users in Finland Hesitant on Using Biosimilars

Nearly half (47%) of biosimilar users knew they were using biosimilars but 31% thought the medicine was an originator. In contrast, 80% of originator users knew they were using an originator, and none thought they were using a biosimilar.

Related Keywords

Finland ,Linkedin Mari ,European Medicines Agency ,Oriola Corporation ,Expert Services ,Medicine Act ,Biosimiliars ,Biosimilars ,Orginator ,Reference Product ,Finland Interchange ,